Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Glass

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 14, 2025
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium datasetAndres Arguedas, David Schneck, Erjia Cui, et al.
Cell Systems|December 20, 2016
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's DiseaseNicholas T Seyfried, Eric B Dammer, Vivek Swarup, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 5, 2012
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALSMarkus Otto, Robert Bowser, Martin Turner, et al.
Plos One|April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosisJames D Berry, Jeremy M Shefner, Robin Conwit, et al.
Lancet (London, England)|March 4, 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialAnne-Marie Wills, Jane Hubbard, Eric A Macklin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 6, 2025
ALSUntangled #81: Pyridostigmine (mestinon<sup>®</sup>)Nadia Mansoor, Terry Heiman-Patterson, Eva L Feldman, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 14, 2025
ALSUntangled #78: ZincBenjamin Helmold, George Nathaniel, Paul Barkhaus, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 15, 2022
ALSUntangled #67: rituximabXiaoyan Li, Carmel Armon, Paul Barkhaus, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trialsAngela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
The New England Journal of Medicine|July 9, 2020
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALSTimothy Miller, Merit Cudkowicz, Pamela J Shaw, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 14, 2025
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium datasetAndres Arguedas, David Schneck, Erjia Cui, et al.
Cell Systems|December 20, 2016
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's DiseaseNicholas T Seyfried, Eric B Dammer, Vivek Swarup, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 5, 2012
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALSMarkus Otto, Robert Bowser, Martin Turner, et al.
Plos One|April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosisJames D Berry, Jeremy M Shefner, Robin Conwit, et al.
Lancet (London, England)|March 4, 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialAnne-Marie Wills, Jane Hubbard, Eric A Macklin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 6, 2025
ALSUntangled #81: Pyridostigmine (mestinon<sup>®</sup>)Nadia Mansoor, Terry Heiman-Patterson, Eva L Feldman, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 14, 2025
ALSUntangled #78: ZincBenjamin Helmold, George Nathaniel, Paul Barkhaus, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 15, 2022
ALSUntangled #67: rituximabXiaoyan Li, Carmel Armon, Paul Barkhaus, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trialsAngela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
The New England Journal of Medicine|July 9, 2020
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALSTimothy Miller, Merit Cudkowicz, Pamela J Shaw, et al.
Pageof 12